Gapping up
In reaction to strong earnings/guidance:
- EVER +27.9%, CHGG +13.5%, SHO +13.3%, EVBG +11.3%, ATRS +8.2%, PBI +8.1%, RNG +7.5%, OCN +6.9%, USFD +6.9%, PTON +6.3%, GSX +6%, CMRX +5.5%, PBPB +5.3%, BWXT +5.1%, ADBE +4.9%, CPE +4.5%, USAC +4.3%, CC +4.1%, JKHY +3.7%, SWM +3.7%, VKTX +3.7%, REAL +3.5%, AMRN +3.4%, SXC +3.3%, ZBH +3.3%, WLK +3.1%, THC +2.9%, ELVT +2.9%, AMRC +2.9%, REGN +2.9%, BMCH +2.8%, KR +2.8%, FIS +2.7%, JLL +2.7%, RPD +2.6%, CCC +2.5%, VST +2.3%, BPMC +2.3%, SSTK +2%, TPR +1.8%, HIG +1.7%, MYL +1.7%, SGRY +1.7%, TCMD +1.5%, ITRI +1.5%, TA +1.5%, XEC +1.3%, NS +1.3%, VIRT +1.3%, LAMR +1.2%, IPI +1.2%, FICO +1%, WTR +1%
M&A news:
- TAK +3.3% (divests select OTC and Non-Core Assets to STADA for $660 mln)
- WDAY +0.6% (to acquire Scout RFP for approx. $450 mln in cash)
Other news:
- SHEN +11.4% (to join S&P SmallCap 600, effective prior to the open on November 8)
- XRX +6.7% (restructures relationship with FUJIFILM; to receive $2.3 bln )
- WWE +5.5% (World Wrestling and Saudi General Entertainment Authority expand live event partnership)
- REGN +2.9% (provides update on ongoing Phase 3 development program evaluating Libtayo as monotherapy and combination therapy in first-line patients with advanced non-small cell lung cancer)
- MGI +2.9% (confirms extension of Walmart (WMT) contract)
Analyst comments:
- SIEN +4.9% (upgraded to Outperform from Mkt Perform at William Blair)
- BYND +2.8% (upgraded to Outperform from Mkt Perform at Bernstein)
- ACM +1% (upgraded to Buy from Hold at Deutsche Bank)
- TTD +0.8% (initiated with a Overweight at Stephens)